Accession Number: | 0001209191-20-002501 |
Date: | 2020-01-06 |
Issuer: | VERTEX PHARMACEUTICALS INC / MA (VRTX) |
Original Submission Date: |
PARINI MICHAEL
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON, MA 02210
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-01-06 | M | 4,250 | a | $122.45 | 39,253 | direct | ||
COMMON STOCK | 2020-01-06 | S | 400 | d | $218.93 | 38,853 | direct | ||
COMMON STOCK | 2020-01-06 | S | 461 | d | $220.69 | 38,392 | direct | ||
COMMON STOCK | 2020-01-06 | S | 1,599 | d | $221.49 | 36,793 | direct | ||
COMMON STOCK | 2020-01-06 | S | 398 | d | $222.67 | 36,395 | direct | ||
COMMON STOCK | 2020-01-06 | S | 1,063 | d | $223.60 | 35,332 | direct | ||
COMMON STOCK | 2020-01-06 | S | 329 | d | $224.11 | 35,003 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 122.45 | 2020-01-06 | deemed execution date | M | 4,250 (d) | 2026-01-03 | common stock 4,250 | $122.45 | 0 | direct |
ID | footnote |
---|---|
f1 | transaction made pursuant to mr. parini's company-approved trading plan under rule 10b5-1. |
f2 | open market sales reported on this line occurred at a weighted average price of $218.93 (range $218.40 to $219.37). |
f3 | mr. parini undertakes to provide (upon request by the sec staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
f4 | open market sales reported on this line occurred at a weighted average price of $220.69 (range $220.32 to $220.99). |
f5 | open market sales reported on this line occurred at a weighted average price of $221.49 (range $221.00 to $221.82). |
f6 | open market sales reported on this line occurred at a weighted average price of $222.67 (range $222.14 to $222.99). |
f7 | open market sales reported on this line occurred at a weighted average price of $223.60 (range $223.19 to $223.99). |
f8 | open market sales reported on this line occurred at a weighted average price of $224.11 (range $224.02 to $224.27). |
f9 | fully vested. |